Our experts in cell therapy manufacturing will take you through all the stages of your regenerative medicine project.

Our clinical stem cell services:

Clinical iPSC Production Service

GMP iMSC & MSC Production Service

Ready-to-use
GMP Mesenchymal Stem Cells

iPSC-derived Exosome Production Service

Ready-to-use
iPSC-Derived Exosomes

StemEdit™
Gene Editing Service

Developing cellular therapies requires strict adherence to manufacturing and regulatory standards that are different for each national regulatory agency. REPROCELL can help you through all stages of your regenerative medicine project.

Cell-based therapies have significant potential to provide patient relief in a broad range of disease areas, from cancer to degenerative disorders. Many of these projects start with iPSCs (induced pluripotent stem cells) or with MSCs (mesenchymal stem cells). Master cell banks (MCBs) can be effectively generated from these stem cells,  ensuring product consistency while managing risk by eliminating contamination and genetic instability.

Specifically, iPSCs are straightforward to manipulate genetically, and the modified iPSCs open the path for innovative therapeutics. Some examples include gene correction for the therapeutic rescue of genetic diseases, the addition of genes at precise genome sites, and the creation of hypoimmune lines that can overcome HLA mismatches.

Whether your project starts with iPSCs or MSCs as the source for your stem cell-based therapeutic project, or if you are interested in clinical gene editing, REPROCELL can assist you!

REPROCELL is a global company that serves customers all around the world. Our worldwide presence ensures that our client's cell therapy projects are compliant with the regulatory standards and guidelines of the FDA, EMA, and PMDA. We will provide the necessary quality and regulatory documents including donor eligibility, CoAs, batch records, traceability documentation, and quality technical agreements for your GMP Master Cell Bank or Cell Therapy product.

REPROCELL’s Clinical Stem Cell Services

Clinical iPSC Production Service

REPROCELL can provide you with clinical iPSCs for your therapeutic project, created with our state-of-the-art RNA reprogramming technology. You can test our clonal lines for suitability before scaling up to a GMP Master Cell Bank.

Discover more

GMP iMSC & MSC Production Service

Whatever the source of MSCs or derivatives thereof you need, REPROCELL can help you drive your next clinical MSC project to success and ensure compliancy with regulatory agencies.

Discover more

Ready-to-use GMP Mesenchymal Stem Cells

High-quality GMP Mesenchymal Stem Cells (MSCs, also called “Mesenchymal Stromal Cells”) provided in partnership with Cellcolabs in Solna, Sweden.

Discover more

StemEdit™ Clinical Gene Editing Service

Using CRISPR-SNIPER, our StemEdit clinical gene editing service enables you to achieve the genotype you need before moving on to expensive cell bank manufacturing processes.

Discover more